Melatonin as a radioprotective agent: A review

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 3, 2004, Pages 639-653

  Vijayalaxmi, ^a   Reiter, Russel J ^a   Tan, Dun Xian ^a   Herman, Terence S ^a   Thomas Jr , Charles R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Antioxidant; Free radicals; Ionizing radiation; Melatonin; Radiation protection; Radiation terrorism

Indexed keywords

HYDROXYLATION; IMMUNOLOGY; IONIZING RADIATION; MEDICAL IMAGING; SCAVENGING; TOXIC MATERIALS;

ANTIOXIDANT; MELATONIN; PINEAL GLAND;

BRAIN;

AMIFOSTINE; ANDROSTENEDIOL; CYSTAFOS; HYDROXYL RADICAL; IOSAT; MELATONIN; POTASSIUM IODIDE; RADIOPROTECTIVE AGENT; SCAVENGER; UNCLASSIFIED DRUG; WR 1607;

ACUTE TOXICITY; CANCER RADIOTHERAPY; CHERNOBYL ACCIDENT; CHRONIC TOXICITY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HOT FLUSH; HUMAN; HYPOCALCEMIA; HYPOTENSION; IONIZING RADIATION; NAUSEA; NONHUMAN; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SNEEZING; SOMNOLENCE; TERRORISM; TOXICITY; VOMITING;

EID: 2942597644     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.02.006     Document Type: Article

References (219)

1. Lerner A.B., Case J.D., Takahasi Y., et al. Isolation of melatonin, a pineal gland factor that lightens melanocytes. J Am Chem Soc. 80:1958;2587
2. Lerner A.B., Case J.D., Heinselman R.V. Structure of melatonin. J Am Chem Soc. 81:1959;6084-6085
3. Axelrod J., Weissbach H. Enzymatic O-methylation of N-acetylserotonin to melatonin. Science. 131:1960;1312-1313
4. Weissbach H., Redfield B.G., Axelrod J. Biosynthesis of melatonin Enzymatic conversion of serotonin to N-acetylserotonin. Biochim Biophys Acta. 43:1960;352-353
5. Sugden D. Circadian changes in rat pineal tryptophan content Lack of correlation with serum tryptophan. J Neurochem. 33:1979;811-813
6. Reiter R.J. Pineal melatonin The biology of its synthesis and of its physiological interactions. Endocr Rev. 12:1991;151-180
7. Snyder S.H., Axelrod J. Circadian rhythm in the serotonin content in the pineal gland Regulating factors. J Pharmacol Exp Ther. 158:1967;206-213
8. Pelham R.W., Vaughan G.M., Sandock K.L., et al. Twenty-four-hour cycle of melatonin-like substance in the plasma of human males. J Clin Endocrinol Metab. 37:1973;341-344
9. Fellenberg A.J., Phillipou G., Seamark R.F. Measurement of urinary production rates of melatonin as an index of human pineal function. Endocr Res Commun. 7:1980;167-175
10. Waldhauser F., Dietzel M. Daily and annual rhythm in human melatonin secretion Role in puberty control. Ann N Y Acad Sci. 453:1985;205-214
11. Reiter R.J. Melatonin. The chemical expression of darkness. Mol Cell Endocrinol. 79:1991;C153-C158
12. Claustrat B., Geoffriau M., Brun J., et al. Melatonin in humans A biochemical marker of the circadian clock and an endogenous synchronizer. Neurophysiol Clin Sci. 2:1995;351-359
13. Pardridge W.M., Meitus L.J. Transport of albumin-bound melatonin through the blood-brain barrier. J Neurochem. 34:1980;1761-1763
14. Kennaway D.J., Voultsios A. Circadian rhythm of free melatonin in human plasma. J Clin Endocrinol Metab. 83:1998;1013-1015
15. Reiter R.J. Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm. 21:1986;35-54
16. Tan D.X., Manchester L.C., Reiter R.J., et al. High physiological levels of melatonin in bile of mammals. Life Sci. 65:1999;523-529
17. Hedlund L., Lischko M.M., Rollag M.D., et al. Melatonin cycle in plasma and cerebrospinal fluid of calves. Science. 195:1976;686-687
18. Shaw P.F., Kennaway D.J., Seamark R.F. Evidence of high concentrations of melatonin in lateral ventricular cerebrospinal fluid of sheep. J Pineal Res. 6:1989;201-208
19. Rousseau A., Petren S., Planntin J., et al. Serum and cerebrospinal fluid concentrations of melatonin A pilot study in healthy male volunteers. J Neural Transm. 106:1999;883-888
20. Vakkuri O. Diurnal rhythm of melatonin in human saliva. Acta Physiol Scand. 124:1985;409-412
21. Nowak R., McMillen I.C., Redman J., et al. The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates Two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol (Oxf). 27:1987;445-452
22. Brzenzinski A., Seibel M.M., Lynch H.J., et al. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab. 64:1987;865-867
23. Bornman M.S., Oosthuizen J.M.C., Barnard H.C., et al. Melatonin and sperm motility. Andrologia. 21:1989;483-485
24. Kivela K., Kauppila A., Leppaluoto J., et al. Serum and amniotic fluid melatonin during human labor. J Clin Endocrinol Metab. 69:1989;1065-1068
25. Sack R.L., Lewy A.J., Erb D.L., et al. Human melatonin production decreases with age. J Pineal Res. 3:1986;379-388
26. Poeggeler B., Reiter R.J., Tan D.X. Melatonin, hydroxyl radical-mediated oxidative damage, and aging A hypothesis. J Pineal Res. 14:1993;151-168
27. Reiter R.J., Guerrero J.M., Garcia J.J., et al. Reactive oxygen intermediaries, molecular damage, and aging. Relation to melatonin. Ann N Y Acad Sci. 854:1998;410-424
28. Arato M., Grof E., Grof P., et al. Reproducibility of the overnight melatonin secretion pattern in healthy men. Brown G.M., Wainwright S.D. Advances in Biosciences. 1985;277-282 Pergamon Press, New York, NY
29. Bojkowski C.J., Arendt J., Shih M.C., et al. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem. 33:1987;1343-1348
30. Kivela A., Kauppila A., Ylostao P., et al. Seasonal, menstrual and circadian secretions of melatonin, gonadotropins and prolactin in women. Acta Physiol Scand. 132:1988;321-327
31. Touitou F., Fevre M., Bogdan A., et al. Patterns of plasma melatonin with ageing and mental condition Stability of nyctohemeral rhythms and differences in seasonal variations. Acta Endocrinol Copenh. 106:1984;145-151
32. Lane E.A., Moss H.B. Pharmacokinetics of melatonin in man First pass hepatic metabolism. J Clin Endocrinol Metab. 61:1985;1214-1216
33. Mallo C., Zaidan R., Galy G., et al. Pharmacokinetics of melatonin in man after intravenous infusion and bolus injection. Eur J Clin Pharmacol. 38:1990;297-301
34. Fellenberg A.J., Phillipou G., Seamark R.F. Urinary 6-sulfatoxymelatonin excretion and melatonin production rate: Studies in sheep and man. Matthews C.D., Seamark R.F. Pineal function. 1981;143-149 Elsevier, Amsterdam
35. Young I.M., Leon R.M., Francis P., et al. Melatonin is metabolized to N-acetyl serotonin and 6-hydroxymelatonin in man. J Clin Endocrinol Metab. 60:1985;114-119
36. Raynaud F., Mauviard F., Geoffriau M., et al. Plasma 6-hydroxymaleatonin, 6-sulphatoxymelatonin and melatonin kinetics after melatonin administration in rats. Bil Signals. 2:1993;358-366
37. Tan D.X., Manchester L.C., Reiter R.J., et al. Cyclic 3-hydroxymelatonin A melatonin metabolite generated as a result of hydroxyl radical scavenging. Biol Signals Recept. 8:1999;70-74
38. Liu R.Y., Zhou J.N., van Heerikhuize J., et al. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer's disease, and apolipoprotein E-epsilon4/4 genotype. J Clin Endocrinol Metab. 84:1999;323-327
39. Almay B.G., von Knorring L., Wetterberg L. Melatonin in serum and urine in patients with idiopathic pain syndromes. Psychiatry Res. 22:1987;179-191
40. Mormont M.C., Langouet A.M., Claustrat B., et al. Marker rhythms of circadian system function A study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int. 19:2002;141-155
41. Brugger P., Marktl W., Herold M. Impaired nocturnal secretion of melatonin in coronary heart disease. Lancet. 345:1995;1408
42. Uchida K., Okamoto N., Ohara K., et al. Daily rhythm of serum melatonin in patients with dementia of the degenerate type. Brain Res. 717:1996;154-159
43. Mishima K., Tozawa T., Satoh K., et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking. Biol Psychiatry. 45:1999;417-421
44. Claustrat B., Loisy C., Brun J., et al. Nocturnal plasma melatonin levels in migraine A preliminary report. Headache. 29:1989;242-245
45. Brun J., Claustrat B., Saddier P., Chazot G. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalagia. 15:1995;136-139
46. Tetsuo M., Polinsky R.J., Markey S.P., et al. Urinary 6-hydroxymelatonin excretion in patients with orthostatic hypotension. J Clin Endocrinol Metab. 53:1981;607-610
47. Fanget F., Claustrat B., Dalery J., et al. Nocturnal plasma melatonin levels in schizophrenic patients. Biol Psychiatry. 25:1989;499-501
48. McIntyre I.M., Norman T.R., Burrows G.D. Melatonin supersensitivity to dim light in seasonal affective disorder. Lancet. 335:1990;488
49. Vijayalaxmi, Selva M, Reiter RJ, et al. Influence of radiotherapy on 6-sulphatoxymelatonin levels in the urine of brain cancer patients. Neuroendocrinology Let 1999;21:203-207
50. Bartsch C., Bartsch H., Jain A.K., Laumas K.R., Wetterberg L. Urinary melatonin levels in human breast cancer patients. J Neural Transm. 52:1981;281-294
51. Stewart J.W., Halbreich U. Plasma melatonin levels in depressed patients before and after treatment with antidepressant medication. Biol Psychiatry. 25:1989;33-38
52. Berga S.L., Mortola J.F., Yen S.S. Amplification of nocturnal melatonin secretion in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab. 66:1988;242-244
53. Kennedy S.H., Garfinkel P.E., Parienti V., et al. Changes in melatonin levels but not cortisol levels are associated with depression in patients with eating disorders. Arch Gen Psychiatry. 46:1989;73-78
54. Schober E., Waldhauser F., Frisch H., et al. Melatonin secretion in Turner's syndrome lack of effect of oestrogen administration. Endocrinol (Oxf). 31:1989;475-479
55. Vollrath L., Semm P., Gammel G. Sleep induction by intranasal application of melatonin. Birau N., Schloot W. Melatonin - Current status and perspectives. 1981;129-133 Pergamon Press, New York, NY
56. Lee B.J., Parrott K.A., Ayres J.W., et al. Preliminary evaluation of transdermal delivery of melatonin in human subjects. Res Commun Mol Pathol Pharmacol. 85:1994;337-346
57. Zhdanova I.V., Wurtman R.J., Morabito C., Piotrovska V.R., Lynch H.J. Effects of low oral dose of melatonin, given 2-4 hours before habitual bedtime, on sleep in normal young humans. Sleep. 19:1996;423-431
58. Benes L., Claustrat B., Horriere F., et al. Transmucosal, oral controlled-release, and transdermal drug administration in human subjects. A crossover study with melatonin. J Pharm Sci. 86:1997;1115-1119
59. Costa E.J.X., Lopes R.H., Lamy-Freund M.T. Solubility of lipid bilayers to melatonin. J Pineal Res. 19:1995;123-126
60. Costa E.J.X., Shida C.S., Biaggi M.H., et al. How melatonin interacts with lipid layers A study by fluorescence and ESR spectroscopies. FEBS Lett. 416:1997;103-106
61. Shida C.S., Castrucci A.M.L., Lamy-Freund M.T. High melatonin solubility in aqueous media. J Pineal Res. 16:1994;198-204
62. Cavallo A., Hassan M. Stability of melatonin in aqueous solution. J Pineal Res. 18:1994;90-92
63. Menendez-Peleaz A., Poeggeler B., Reiter R.J., et al. Nuclear localization of melatonin in different mammalian tissues Immunocytochemical and radioimmunoassay evidence. J Cell Biochem. 53:1993;372-382
64. Finnochiaro L.M.E., Glikin G.C. Intracellular melatonin distribution in cultured cell lines. J Pineal Res. 24:1998;22-34
65. Acuna-Castroviejo D., Martin M., Macias M., et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res. 30:2001;65-74
66. Ianas O., Olnescu R., Badescu I. Melatonin involvement in oxidative stress. Rom J Endocrinol. 29:1991;147-153
67. Reiter R.J., Melchiorri D., Sewerynek E., et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res. 18:1995;1-11
68. Marshall K., Reiter R.J., Poeggeler B., et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med. 21:1996;307-315
69. Reiter R.J., Tan D.X., Cabrera J., et al. Melatonin and tryptophan derivatives as free radical scavengers and antioxidants. Adv Exp Med Biol. 467:1999;379-387
70. Reiter R.J., Tan D.X., Acuna-Castroviejo D., et al. Melatonin Mechanisms and actions as an antioxidant. Curr Top Biophys. 24:2000;171-183
71. Tan D.X., Manchester L.C., Burkhardt S., et al. N-acetyl-N-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J. 15:2001;2294-2296
72. Gitto E., Tan D.X., Reiter R.J., et al. Individual and synergistic antioxidative actions of melatonin Studies with vitamin E, vitamin C, glutathione and desferoxamine in liver homogenates. J Pharm Pharmacol. 53:2001;1393-1401
73. Reiter R.J., Tong L., Garcia I.J., et al. Pharmacological actions of melatonin in free radical pathophysiology. Life Sci. 60:1997;255-271
74. Reiter R.J., Acuna-Castroviejo D., Tan D.X., et al. Free radical-mediated molecular damage Mechanisms for the protective actions of melatonin in the central nervous system. Ann N Y Acad Sci. 939:2001;200-215
75. Livrea A., Tesoriere L., Tax D.X., et al. Radical and reactive intermediate-scavenging properties of melatonin in pure chemical systems. Cadenas E., Parker L. Handbook of antooxidants. 2002;615-631 Raven Press, New York
76. Allegra M., Reiter R.J., Tan D.X., et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res. 34:2003;1-10
77. Tan D.X., Chen L.D., Poeggeler B., et al. Melatonin A potent, endogenous hydroxyl radical scavenger. Endocrine J. 1:1993;57-60
78. Poeggeler B., Reiter R.J., Hardeland R., et al. Melatonin and structurally related endogenous indoles act as potent electron donors and radical scavenger in vitro. Redox Rep. 2:1996;179-184
79. Matsuszak Z., Reszka K.J., Chignell C.H. Reaction of melatonin and related indoles with hydroxyl radicals ESR and spin trapping investigations. Free Radic Biol Med. 23:1997;367-372
80. Stasica P., Ulanski P., Rosiak J.M. Melatonin as a hydroxyl radical scavenger. J Pineal Res. 25:1998;65-66
81. Bromme H.J., Morke W., Penkbe E., et al. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res. 29:2000;201-208
82. 2 induced lipid peroxidation in homogenates of different rat brain regions. J Pineal Res. 19:1995;51-56
83. Romero M.P., Osuna C., Garcia-Perganeda A., et al. The pineal secretory product melatonin reduces hydrogen peroxide-induced DNA damage in U-937 cells. J Pineal Res. 26:1999;227-235
84. 2 Protection by melatonin and related molecules. J Pineal Res. 29:2000;54-61
85. Tan D.X., Manchester L.C., Reiter R.J., et al. Melatonin directly scavenges hydrogen peroxide A potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med. 29:2000;1177-1185
86. 2. J Pineal Res. 24:2003;134-142
87. Pieri C., Marra M., Monari R., et al. Melatonin. A peroxyl radical scavenger more potent than vitamin E. Life Sci. 55:1994;PL271-PL276
88. Cagnoli C.M., Atabay C., Kharlamova E., et al. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res. 18:1995;222-226
89. 2-formyl-5[prime]- methoxynuramine. J Pineal Res 2003, in press
90. Noda Y., Mori A., Liburdy R., et al. Melatonin and its precursors scavenge nitric oxide. J Pineal Res. 27:1999;159-163
91. Blanchard B., Pompon D., Ducrocq C. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res. 29:2000;184-192
92. Turjanski A.G., Saurz D.A., Doctorovich F., et al. Nitrosation of melatonin by nitric oxide. A computational study. J Am Chem Soc. 37:2001;97-101
93. Gilad E., Cuzzocrea S., Zingarelli B., et al. Melatonin is a scavenger of peroxynitrite. Life Sci. 60:1997;PL169-PL174
94. Kelly M.R., Loo G. Melatonin inhibit oxidative modification of human low-density lipoprotein. J Pineal Res. 22:1997;203-209
95. Rousselot D.B., Cheve G., Gozzo A., et al. Melatonin related compounds inhibit lipid peroxidation during copper or free radical-induced LDL oxidation. J Pineal Res. 33:2002;109-117
96. Sewerynek E., Melchiorri D., Reiter R.J., et al. Lipopolysaccharide- induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol. 293:1995;327-334
97. Garcia J.J., Reiter R.J., Guerrero J.M., et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett. 408:1997;297-300
98. Karbownik M., Reiter R.J., Qi W., et al. Protective effects of melatonin against oxidation of guanine bases in DNA and decreased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Mol Cell Biochem. 211:2000;137-144
99. Barlow-Walden L.R., Reiter R.J., Abe A., et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int. 26:1995;497-502
100. Antolin I., Rodriquez C., Sainz R.M., et al. Neurohormone melatonin prevents cell damage Effect of gene expression for antioxidative enzymes. FASEB J. 10:1996;882-890
101. Guerrero J.M., Reiter R.J., Oritz G.G., et al. Melatonin prevents increases in neural nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (meriones unguiculatus). J Pineal Res. 23:1997;24-31
102. Kotler M., Rodriguez C., Sainz R.M., et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res. 24:1998;83-89
103. Pablos M.I., Reiter R.J., Ortiz G.G., et al. Rhythms of glutathione peroxidase and glutathione reductase in the brain of chicks and their inhibition by light. Neurochem Int. 32:1998;69-75
104. Reiter R.J., Tan D.X., Osuna C., et al. Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci. 7:2000;444-458
105. Reiter R.J., Tan D.X., Manchester L.C., et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species. A review of the evidence. Cell Biochem Biophys. 34:2001;237-256
106. Blickenstaff R.T., Brandstadter S.M., Reddy S., et al. Potential radioprotective agents 1. Homologues of melatonin. J Pharm Sci. 83:1994;216-218
107. Vijayalaxmi, Meltz ML, Reiter RJ, et al. Melatonin and protection from whole-body irradiation: Survival studies in mice. Mutat Res 1999;425:21-27
108. Vijayalaxmi, Meltz ML, Reiter RJ, et al. Melatonin and protection from genetic damage in blood and bone marrow: Whole-body irradiation studies in mice. J Pineal Res 1999;27:221-225
109. Jahnke G., Marr M., Myers C., et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague Dawley rats. Toxicol Sci. 50:1999;271-279
110. Kaya H., Delibas N., Serteser M., et al. The effect of melatonin on lipid peroxidation during radiotherapy in female rats. Strahlenther Onkol. 175:1999;285-288
111. Barchas J., DeCosta F., Spector S. Acute pharmacology of melatonin. Nature (London). 214:1967;919-921
112. Lieberman H.R., Waldhausser F., Garfield G., et al. Effects of melatonin on human mood and performance. Brain Res. 323:1984;201-207
113. Arendt M., Aldhous M., Marks V. Alleviation of jet lag by melatonin Preliminary results of controlled double-blind trial. Br Med J Clin Res. 292:1986;1170
114. Lissoni P., Barni S., Crispino S., et al. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol. 25:1989;789-795
115. James S.P., Sack D.A., Rosenthal N.E., et al. Melatonin administration and insomnia. Neuropsychopharmacology. 3:1990;19-23
116. Sarnel A., Wegmann A.M., Vejvoda M., et al. Influence of melatonin treatment on human circadian rhythmicity before and after a simulated 9-hour shift. J Biol Rhythms. 6:1991;235-248
117. Voordouw B.C., Euser R., Verdonk R.E., et al. Melatonin and melatonin-progestin combinations alter pituitary-ovarian function and can inhibit ovulation. J Clin Endocrinol Metab. 74:1992;108-117
118. Lissoni P., Barni S., Roveli F., et al. Neuroimmunotherapy of advanced solid neoplasm with single evening subcutaneous injection of low-dose interleukin-2 and melatonin Preliminary results. Eur J Cancer. 29:1993;185-189
119. Vijayalaxmi, Reiter RJ, Herman TS, et al. Melatonin and radioprotection from genetic damage: In vivo/in vitro studies with human volunteers. Mutat Res 1996;371:221-228
120. Nordlund J.J., Lerner A.B. The effects of oral melatonin on skin color and on the release of pituitary hormones. J Clin Endocrinol Metab. 45:1977;768-774
121. Sebra M.L.V., Bignotto M., Pinto L.R. Jr., et al. Randomized, double-blind clinical trial, controlled with placebo, of the toxicology of chronic melatonin treatment. J Pineal Res. 29:2000;193-200
122. Folkard S., Arendt J., Aldhous M., et al. Melatonin stabilizes sleep onset time in a blind man without entrainment of cortisol or temperature rhythms. Neurosci Lett. 113:1990;193-198
123. De Vries M.W., Peters F.P.M.L. Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression. J Nerv Ment Dis. 183:1997;201-202
124. Hughes R.J., Sack R.L., Lewy A.J. The role of melatonin and circadian phase in age-related sleep-maintenance insomnia Assessment in a clinical trial of melatonin replacement. Sleep. 21:1998;52-68
125. Sack R.L., Lewy A.J., Hughes R.J. Use of melatonin for sleep and circadian rhythm disorders. Ann Med. 30:1998;115-121
126. Brusco L.I., Fainstein I., Marquez M., et al. Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept. 8:1999;126-131
127. O'Callaghan F.J., Clarke A.A., Hancock E., et al. Use of melatonin to treat sleep disorders in tuberous sclerosis. Dev Med Child Neurol. 141:1999;123-126
128. Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signals Recept. 8:1999;84-89
129. Claustrat B., Brun J., David M., et al. Melatonin and jet lag Confirmatory results using a simplified protocol. Biol Psychiatry. 32:1992;705-711
130. Suhner A., Schlagenhauf P., Johnson R., et al. Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag. Chronobiol Int. 15:1998;655-666
131. Anton T.F., Diaz J.L., Fernandez G.A. On the effect of melatonin upon human brain. Its possible therapeutic implications. Life Sci. 10:1971;841-850
132. Lissoni P., Barni S., Crispino S., et al. Endocrine and immune effects of melatonin therapy in metastatic cancer patients. Eur J Cancer Clin Oncol. 25:1989;789-795
133. Lissoni P., Barni S., Ardizzoia A., et al. Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients. J Biol Reg Homeos Agents. 6:1992;132-136
134. Lissoni P., Brivio F., Brivio O., et al. Immune effects of preoperative immunotherapy with high-dose subcutaneous interleukin-2 versus neuroimmunotherapy with low-dose interleukin-2 plus the neurohormone melatonin in gastrointestinal tract tumor patients. J Biol Regul Homeost Agents. 9:1995;31-33
135. Conti A., Maestroni G.J.M. The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res. 19:1995;103-110
136. Maestroni G.J.M., Conti A., Reiter R.J. Therapeutic potential of melatonin. Frontiers of Hormone Research 23. 1997;Karger, Basel
137. Arendt J., Deacon S. Treatment of circadian rhythm disorders-melatonin. Chronobiol Int. 14:1997;185-204
138. Cupp M.J. Melatonin. Am Fam Physician. 56:1997;1421-1425
139. Dollins A.B., Lynch H.J., Wurtman R.J., et al. Effect of pharmacological daytime doses of melatonin on human mood and performance. Psychopharmacology. 112:1993;490-496
140. Dollins A., Zhdanova I.V., Wurtman R.J., et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A. 91:1994;1824-1828
141. Rogers N.L., Phan O., Kennaway D.J., et al. Effect of daytime oral melatonin administration on neurobehavioral performance in humans. J Pineal Res. 25:1998;47-53
142. Carman J.S., Post R.M., Buswell R., et al. Negative effects of melatonin on depression. Am J Psychiatry. 133:1976;1181-1186
143. Ward J.F. DNA damage produced by ionizing radiation in mammalian cells Identities, mechanisms of formation and repairability. Prog Nucleic Acid Res Mol Biol. 35:1988;95-125
144. Floyd R.A. The role of 8-hydroxydeoxyguanosine in carcinogenesis. Carcinogenesis. 11:1990;1447-1450
145. Haegele A.D., Wolfe P., Thompson H.J. X-radiation induced 8-hydroxy-2[prime]-deoxyguanosine formation in vivo in rat mammary gland DNA. Carcinogenesis. 19:1998;1319-1321
146. Breen A.P., Murphy J.A. Reactions of oxyl radicals with DNA. Free Radic Biol Med. 18:1995;1033-1077
147. Cadet J., Delatour T., Douki T., et al. Hydroxyl radicals and DNA base damage. Mutat Res. 424:1999;9-21
148. Halliwell B., Aruoma O.I. DNA damage by oxygen-derived species. FEBS Lett. 281:1990;9-19
149. Elia M.C., DeLuca J.G., Bradley M.O. Significance and measurement of DNA double strand breaks in mammalian cells. Pharmacol Ther. 51:1991;291-327
150. Sankaranarayanan K. Ionizing radiation and genetic risks. X. The potential "disease phenotypes" of radiation-induced genetic damage in humans: Perspectives from human molecular biology and radiation genetics. Mutat Res 1999;429:45-83
151. Edwards J.C., Chapman D., Cramp W.A., et al. The effects of ionizing radiation on biomembrane structure and function. Prog Biophys Mol Biol. 43:1984;71-93
152. Verma S.P., Sonwalker N. Structural changes in plasma membranes prepared from irradiated Chinese hamster V79 cells as revealed by Raman spectroscopy. Radiat Res. 126:1991;27-35
153. Parasassi T., Giusti A.M., Gratton E., et al. Evidence for an increase in water concentration in bilayers after oxidative damage of phospholipids induced by ionizing radiation. Int J Radiat Biol. 65:1994;329-334
154. Gusti A.M., Raimondi M., Rahavan G., et al. Human cell membrane oxidative damage induced by single and fractionated doses of ionizing radiation A fluorescence spectroscopy study. Int J Radiat Biol. 74:1998;595-605
155. Jhun E., Jhun B.H., Jones L.R. Direct effects of ionizing radiation on integral membrane proteins. J Biol Chem. 266:1991;9403-9407
156. Pohl L.R. An immunochemical approach of identifying and characterizing protein targets of toxic reactive metabolites. Chem Res Toxicol. 6:1993;786-793
157. Becker D., Sevilla M.D. The chemical consequences of radiation damage to DNA. Adv Radiat Biol. 17:1993;121-179
158. Riley P.A. Free radicals in biology Oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 65:1994;27-33
159. Jaeschke H. Mechanisms of oxidant stress-induced acute tissue injury. Proc Exp Biol Med. 209:1995;104-111
160. Morgan W.F., Day J.P., Kaplan M.I., et al. Genomic instability induced by ionizing radiation. Radiat Res. 146:1996;247-258
161. Natarajan AT, Vyas RC, Darroudi F, et al. DNA lesions, DNA repair and chromosomal aberrations. In: Chromosomal aberrations, basic and applied aspects. Obe G, Natarajan AT, editors. Berlin: Springer-Verlag 1990; p. 116-125
162. Tchou J., Grollman A.P. Repair of DNA containing the oxidatively damaged base, 8-oxyguanine. Mutat Res. 299:1993;277-287
163. Wallace S.S. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res. 150:1998;S60-S79
164. Sies H. Strategies of antioxidant defense. Eur J Biochem. 215:1993;213-219
165. Chevion S., Or R., Berry E.M. The antioxidant status of patients subjected to total body irradiation. Biochem Mol Biol Int. 47:1999;1019-1027
166. Ikushima T., Aritomi H., Morisita J. Radioadaptive response Efficient repair of radiation-induced DNA damage in adapted cells. Mutat Res. 358:1996;193-198
167. 60Co -rays on sperm shape abnormalities, lipid peroxidation, and superoxide [graphic not provided] dismutase (SOD) activity induced by subsequent high-dose irradiation. Int J Radiat Biol. 73:1998;163-167
168. Wolff S. The adaptive response in radiobiology Evolving insights and implications. Environ Health Perspect. 106:1998;277-283
169. Feinendegen L.E. The role of adaptive responses following exposure to ionizing radiation. Hum Exp Toxicol. 18:1999;426-432
170. Dale WM, Gray LH, Meredith WJ. The inactivation of an enzyme (Carboxypeptidase) by X- and α-radiation. Philos Trans R Soc Lond A Math Phy Sci 1949;242:33-62
171. Patt H.M., Turee E.B., Straube R.L., Smith D.E. Cysteine protection against X irradiation. Science. 110:1949;213-214
172. Becq Z.M., Herve A., Lecomte J., et al. Protection contre le rayonnement X par la [graphic not provided] mercaptoethylamine. Arch Int Physiol. 59:1951;442-447
173. Bump EA, Malakar K. Radioprotectors: Chemical, biological and clinical perspectives. Bump EA, Malakar K, editors. Boca Raton: CRC Press; 1997
174. Yuhas J.M., Spellman J.M., Culo F. The role of WR-2721 in radiotherapy and/or chemotherapy. Cancer Clin Trials. 3:1980;211-216
175. Glover D.J., Riley L., Carmichael K., et al. Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent). N Engl J Med. 309:1983;1137. &n radio-therapy dash;1141
176. Kligerman M.M., Glover D.J., Turrisi A.T., et al. Toxicity of WR-2721 administered in single and multiple doses. Int J Radiat Oncol Biol. Biophys. 10:1984;1773-1776
177. Schuchter L.M., Glick J.H. The current status of WR-2721 (amifostine): A chemotherapy and radiotherapy protector. DeVita V.T., Hellman S., Rosenberg S.A. Biologic therapy of cancer updates. 1993;1-10 Lippincott, Philadelphia
178. Ainsworth A. From endotoxins to newer immunomodulators Survival promoting effects of microbial polysaccharide complexes in irradiated animals. Pharmacol Ther. 39:1988;223-241
179. Srinivasan V., Weiss J.F. Radioprotection by vitamin E Injectable vitamin E administered alone or with WR 3689 enhances survival of irradiated mice. Int J Radiat Oncol Biol Phys. 23:1992;841-845
180. Sharma L., Kesavan P.C. Protective effect of vitamin C and E against chromosomal aberrations in mouse. Int J Radiat Biol. 63:1993;759-764
181. Ueda T., Toyoshima Y., Kushihahi T., et al. Effect of dimethyl sulfoxide pretreatment on activities of lipid peroxidase formation, superoxide dismutase, and glutathione peroxidase in the mouse liver after whole-body irradiation. J Toxicol Sci. 18:1993;239-244
182. Harapanahalli R.S., Narra V.R., Yaghmai V., et al. Vitamins as radioprotectors in vivo. II. Protection by vitamin A and soybean oil against radiation damage caused by internal radionuclides. Radiat Res. 139:1994;115-122
183. Shimoi K., Masuda S., Furugori M., et al. Radioprotective effect of antioxidative flavinoids in gamma-ray irradiated mice. Carcinogenesis. 15:1994;2669-2672
184. Maurizot S.M., Ruiz S., Sabattier R., et al. Radioprotection of DNA by polyamines. Int J Radiat Biol. 68:1995;571-577
185. Ueda T., Toyoshima Y., Moritani T., et al. Protective effect of dipyridamole against lethality and lipid peroxidation in liver and spleen of the ddY mouse after whole-body irradiation. Int J Radiat Biol. 69:1996;199-204
186. Slyshenkov V.S., Omelyanchik S.N., Moiseenok A.G., et al. Pantothenol protects rats against some deleterious effects of gamma radiation. Free Radic Biol Med. 24:1998;894-899
187. Uma Devi P. Radioprotecive, anticarcinogenic and antioxidant properties of the India holy basil, Ocimum sanctum (Tulasi). Indian J Exp Biol. 39:2001;185-190
188. Bangha E., Elsner P., Kistlet G.Z. Suppression of UV-induced erythemia by topical treatment with melatonin (N-acetyl-5-methoxytryptamine). A dose-response study. Arch Dermatol Res. 288:1996;522-526
189. Dreher F., Gabard B., Schwardt D.A., et al. Topical melatonin in combination with vitamins E and C protects skin from ultraviolet-induced erythemia A human study in vivo. Br J Dermatol. 139:1998;332-339
190. Fischer T.W., Acholz G., Knoll B., et al. Melatonin reduces UV-induced reactive oxygen species in a dose-dependent manner in IL-3-stimulated leukocytes. J Pineal Res. 31:2001;39-45
191. Vijayalaxmi, Reiter RJ, Meltz ML. Melatonin protects human blood lymphocytes from radiation-induced chromosome damage. Mutat Res 1995;346:23-31
192. Vijayalaxmi, Reiter RJ, Sewerynek E, et al. Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat Res 1995;143:102-106
193. Vijayalaxmi, Reiter J, Leal BZ, et al. Effect of melatonin on mitotic and proliferation indices and sister chromatid exchange in human blood lymphocytes. Mutat Res 1996;351:187-192
194. Vijayalaxmi, Reiter RJ, Herman TS, et al. Melatonin reduces gamma radiation-induced primary DNA damage in human blood lymphocytes. Mutat Res 1998;397:203-208
195. Vijayalaxmi, Reiter RJ, Meltz ML, et al. Melatonin: Possible mechanisms involved in its 'radioprotective' effect. Mutat Res 1998;404:187-189
196. Musatov S.A., Anisimov V.N., Andre V., et al. Modulatory effects of melatonin on genotoxic response of reference mutagens in the Ames test and the comet assay. Mutat Res. 417:1998;75-84
197. Badr F.M., Habit O.H.M., Harraz M.M. Radioprotective effect of melatonin assayed by measuring chromosomal damage in mitotic and meiotic cells. Mutat Res. 444:1999;367-372
198. Mornjakovic Z., Scepovic M., Kundurovic Z. Morphometric aspects of seminiferous tubules in rats treated with melatonin and whole body irradiation. Med Arch. 45:1991;9-10
199. Mornjakovic Z., Alicelebic S., Bilalovic N., et al. Morphometric characteristics of Leydig cells after total body irradiation of rats treated with melatonin. Med Arch. 52:1998;183-184
200. Kim J.K., Lee C.J., Song K.W., et al. γ-radiation accelerates follicular atresia in immature mice. In Vivo. 23:1999;21-24
201. Kim J.K., Lee C.J. Effect of exogenous melatonin on the ovarian follicles in irradiated mouse. Mutat Res. 449:2000;33-39
202. Ahlers I., Solar P., Ahlersova E., et al. The influence of melatonin in metabolic changes in female rats induced by continuous irradiation and/or administration of 7, 12-dimethylbenz(a)anthracene. Neoplasma. 44:1997;253-257
203. Mehmet KOC, Seyithan T, Mehmet E, et al. Melatonin protects rat liver against irradiation induced oxidative damage. Mutat Res 2003. in print
204. Tesoriere L., D'Arpa D., Conti S., et al. Melatonin protects human red cells from oxidative hemolysis New insights into the radical-scavenging activity. J Pineal Res. 27:1999;95-105
205. Kundurovic Z., Scepovic M. Histoenzymological reactions of the thyroid gland in irradiated and previously melatonin-treated irradiated rats. Acta Med Jugosl. 43:1989;337-347
206. Kundurovic Z., Mornjakovic Z. Morphometric characteristics of thyroid cells in irradiation-stressed rats treated with pinealectomy and melatonin. Med Arch. 46:1992;9-10
207. Sainz R.M., Mayo J.C., Uria H., et al. The pineal neurohormone melatonin prevents in vivo and in vitro apoptosis in thymocytes. J Pineal Res. 19:1995;178-188
208. Siu A.W., Reiter R.J., To C.H. Pineal indolamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates. J Pineal Res. 27:1999;122-128
209. Maestroni G.J.M., Covacci V., Conti A. Hemopoietic rescue via T-cell dependent, endogenous granulocyte-macrophage colony stimulating factor induced by the pineal neurohormone melatonin in tumor-bearing mice. Cancer Res. 54:1994;2429-2432
210. Ruifrok A.C.C., Weil M.M., Thames H.D., et al. Diurnal variation in the expression of radiation-induced apoptosis. Radiat Res. 149:1998;360-365
211. Yavuz M.N., Yanuz A.A., Ulku C., et al. Protective effect of melatonin against fractionated irradiation-induced epiphyseal injury in a weanling rat model. J Pineal Res. 35:2003;288-295
212. Georgiou E. Uber die nature und die Pathogenese der Krebstumren. Radikale Heilung de Krebses bei weiblichen Mauses. Z Krebsforschung. 38:1929;562-572
213. Blask D.E. The melatonin rhythm in cancer patients. Shafi M. Melatonin in psychiatric and neoplastic disorders. 1997;257-275 American Psychiatric Press, Washington, DC
214. Bartsch C., Kvetnoy I., Kvetnaia T., et al. Nocturnal urinary 6-sulfatoxymelatonin and proliferating cell nuclear antigen-immunopositive tumor cells show strong positive correlations in patients with gastrointestinal and lung cancer. J Pineal Res. 23:1997;90-96
215. Vijayalaxmi, Thomas CR Jr., Reiter RJ, et al. Melatonin: From basic research to cancer treatment clinics. J Clin Oncol 2002;20:2575-2601
216. Wolfler A., Abuja P.M., Linkesch W., et al. Questinaly benefit of melatonin for antioxidant pharmacologic therapy. J Clin Oncol. 20:2002;4127
217. Vijayalaxmi, Thomas CE, Reiter RJ. Reply. J Clin Oncol 2002;20:4128-4129
218. Mettler F.A., Voelz G.L. Major radiation exposure - what to expect and how to respond. N Engl J Med. 346:2002;1554-1561
219. Hall E.J. Radioprotectors. Hall E.J. Radiobiology for the radiologist. 2000;136-143 Lippincott Williams and Wilkins, New York